Skip to main content
OpenTrials
Completed

NCT Number: NCT00381576

Multiple Sclerosis and Heavy Progressive Resistance Training

The purpose of the present investigation is to determine whether MS patients can tolerate and benefit from heavy progressive resistance training. A second purpose is to determine both neural and muscle morphological adaptations to heavy progressive resistance training.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Sports Science, University of Aarhus, Aarhus, Denmark

Loading trial locations.

About this study

Multiple sclerosis (MS) patients are characterized by reduced muscle strength and functional capacity. For MS patients, improvements in muscle strength and thereby functional capacity, would have the potential to make both the daily living easier and to extend the time living independently. Attempts to improve muscle strength and function include the application of physical training, although the general advice to MS patients for many years has been to avoid participation in physical training. It has now been demonstrated that endurance training at low to moderate intensity is well tolerated by MS patients, but it only induces modest improvements in both muscle strength and functional capacity. Heavy progressive resistance training (HPRT) has proven to be the most effective means to improve muscle strength and functional capacity during daily activities in healthy older people. However, the effects of HPRT have not been investigated in randomised control trials in MS patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Relapsing Remitting Multiple Sclerosis according to the McDonald criteria
  • Expanded Disability Status Scale Score between 3,0-5,5
  • Be able to walk at least 100m
  • Be able to train twice a week at the University

Exclusion criteria

  • Alcohol abuse, Alzheimer's and pacemaker
  • Comorbidities like cardiovascular-, respiratory-, orthopaedic or metabolic diseases
  • Having had an attack in a period of 8 weeks prior to the start of the intervention period
  • Having an attack during the intervention period
  • Pregnancy
  • Systematic resistance training in a period of 3 months prior to the start of the intervention period.
  • Training adherence of less than 85%.

Treatment and study plan

Resistance training

Behavioral

Intervention group: 12 weeks of resistance training for the lower extremity. Control group: No intervention - 12 weeks of normal daily living

Primary outcomes

  1. Muscle strength (isokinetic testing)

    Time frame: Before and after the intervention

Secondary outcomes

  1. Functional capacity (Six minute walk test, 10m walk test, chair rise, stair climbing)

    Time frame: Before and after the intervention

  2. Muscle biopsies from m. vastus lateralis

    Time frame: Before and after the intervention

  3. % Fat (skinfold)

    Time frame: Before and after the intervention

  4. Blood samples (immunologic parameters)

    Time frame: Before and after the intervention

  5. Fatigue (Fatigue Severity Scale - FSS, Modified Fatigue Inventory - MFI-20)

    Time frame: Before and after the intervention

  6. HRQOL: SF36

    Time frame: Before and after the intervention

  7. Depression: Major Depression Inventory (MDI)

    Time frame: Before and after the intervention

  8. Surface EMG from m. vastus lateralis during MVC

    Time frame: Before and after the intervention

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Collaborators

  • Sonderborg Hospital
  • The Danish Multiple Sclerosis Society

Registry information

Official study title

Multiple Sclerosis and Muscle Function - Effects of Heavy Progressive Resistance Training

Important dates

Study start
2006
Primary completion
2008
Study completion
2008
First posted
Sep 28, 2006
Registry last updated
Aug 12, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.